ReviewClinical reviews in allergy & immunology2026
Tertiary Lymphoid Structure: A Potential Therapeutic Target Affecting Immune Response in Autoimmune Diseases.
Review in Clinical reviews in allergy & immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Autoimmune diseases are characterized by the immune system's breakdown of self-tolerance, and manifest as either organ-specific or systemic conditions. Within the target tissues of diverse autoimmune diseases, tertiary lymphoid structures (TLSs) emerge under persistent inflammatory conditions. These pathological, ectopic lymphoid formations serve as sites for sustained antigen presentation, affinity maturation of antibodies, and proliferation /differentiation of B cells, thereby exacerbating local immune-mediated damage. Given their functional significance, TLSs represent promising candidates as diagnostic biomarkers and novel therapeutic targets for autoimmune pathologies. This review synthesizes the current knowledge on the pathological relevance of TLSs, the mechanisms driving their formation and the therapeutic targeting potential, aiming to deepen the understanding of how TLSs influence the immune microenvironment in autoimmune disease pathology.
Indexed as
Identifiers
42329496What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.